Revolutionizing Alzheimer’s Care: CBD Life Sciences Launches Delta-8 Gummies

A New Hope for Alzheimer’s Patients In a significant move aimed at the burgeoning $6 billion U.S. edibles market, CBD Life Sciences Inc. has unveiled its innovative Delta-8 100mg Gummies, designed specifically for individuals living with Alzheimer’s disease. With an anticipated $3 million in revenue within the first year, these gummies promise to offer relief […]
The post Revolutionizing Alzheimer’s Care: CBD Life Sciences Launches Delta-8 Gummies first appeared on CBD Telegraph.
* This article was originally published here
Comments
Post a Comment